Drugs. Picture: RUSSELL ROBERTS
Drugs. Picture: RUSSELL ROBERTS

Steven Schultz from Momentum chose Bristol-Myers Squibb as his stock pick of the day.

“My stock pick today is a US-listed biopharm by the name of Bristol-Myers Squibb. It is a specialist in immune-oncology treatments and it’s a company that’s been around for 80 years, so an exceptionally strong balance sheet.

Or listen to the full audio:

Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.